AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JUL 4 - (NewsRx.com & NewsRx.net) -- King Pharmaceuticals, Inc., (KG) announced the completion of the company's previously announced acquisition from Ortho-McNeil Pharmaceutical, Inc., a Johnson & Johnson subsidiary, of Ortho-Prefest (estradiol/norgestimate) tablets in the United States, its territories and possessions, and the Commonwealth of Puerto Rico, including the related new drug application, investigational new drug application, copyrights, and patents or licenses to such patents.
Ortho-McNeil will continue to manufacture Ortho-Prefest tablets and supply King's requirements for the product for an initial term of 5 years pursuant to the provisions of a Manufacturing and Supply Agreement between the parties.
Ortho-Prefest tablets offer a single tablet combination hormone replacement therapy with an intermittent or pulsed progestin administration of 3 days on, followed by 3 days off, together with a continuous administration of estrogen. The drug is ...
Source: HighBeam Research, Acquisition of Ortho-Prefest completed.(Brief Article)